1. Home
  2. CPA vs GH Comparison

CPA vs GH Comparison

Compare CPA & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Copa Holdings S.A.

CPA

Copa Holdings S.A.

HOLD

Current Price

$108.74

Market Cap

5.5B

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$84.94

Market Cap

13.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPA
GH
Founded
1947
2011
Country
Panama
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
13.3B
IPO Year
2005
2018

Fundamental Metrics

Financial Performance
Metric
CPA
GH
Price
$108.74
$84.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
20
Target Price
$160.22
$117.80
AVG Volume (30 Days)
486.2K
1.7M
Earning Date
05-06-2026
04-29-2026
Dividend Yield
6.18%
N/A
EPS Growth
N/A
6.74
EPS
N/A
N/A
Revenue
N/A
$982,021,000.00
Revenue This Year
$14.13
$33.40
Revenue Next Year
$6.78
$28.55
P/E Ratio
$9.05
N/A
Revenue Growth
N/A
32.88
52 Week Low
$82.54
$36.36
52 Week High
$156.41
$120.74

Technical Indicators

Market Signals
Indicator
CPA
GH
Relative Strength Index (RSI) 29.33 34.90
Support Level $104.33 $82.26
Resistance Level $111.79 $103.16
Average True Range (ATR) 4.92 3.94
MACD -1.84 0.07
Stochastic Oscillator 5.12 20.02

Price Performance

Historical Comparison
CPA
GH

About CPA Copa Holdings S.A.

Copa Holdings SA is a provider of airline passenger and cargo services through its subsidiaries. The company operates through the air transportation segment. It offers international air transportation for passengers, cargo, and mail, operating from its Panama City hub in the Republic of Panama, and domestic and international air transportation for passengers, cargo, and mail with a point-to-point route network through Copa Colombia, a Colombian air carrier. The company's geographical segments are North America, South America, Central America, and the Caribbean. It derives the maximum revenue from North America.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: